Dipal Patel
Vermögen: 604 691 $ am 31.05.2026
Vermögen: 604 691 $ am 31.05.2026
Dipal Patel is currently the Chief Commercial Officer at Valneva SE.
Previously, Dipal worked as the Head-Global Commercial at GSK Plc from 2019 to 2023.
Before that, Dipal held the position of Vice President-Vaccines Commercialization at GlaxoSmithKline GmbH & Co. KG.
Dipal completed an undergraduate degree at Macquarie University in 1998 and obtained an MBA from Macquarie Graduate School of Management Pty Ltd. in 2006.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VALNEVA SE 0.1% | 31.12.2025 | 198’385 ( 0.1% ) | 604 691 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| VALNEVA SE | Corporate Officer/Principal | 17.11.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01.02.2023 |
GlaxoSmithKline GmbH & Co. KG
GlaxoSmithKline GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Macquarie University
Macquarie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline GmbH & Co. KG
GlaxoSmithKline GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Macquarie Graduate School of Management Pty Ltd.
Macquarie Graduate School of Management Pty Ltd. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valneva SE
Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen